ClinicalTrials.govcontrolled
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chem
ClinicalTrials.gov study NCT06793709. IPD Sharing: YES. Countries: 1. Publications: 0.
ShareScore
20/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 4
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 4